Top

ADHD Attention Deficit and Hyperactivity Disorders

Published in:

01-09-2019 | Attention Deficit Hyperactivity Disorder | Original Article

Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study

Authors: Lizbett Flores-García, Michael B. Lensing, Elinor Ytterstad, Martin Eisemann

Published in: ADHD Attention Deficit and Hyperactivity Disorders | Issue 3/2019

Abstract

There is sparse research on quality of life (QoL) as an outcome measure in patients with substance use disorders (SUD), with or without attention deficit hyperactivity disorder (ADHD). We aimed to investigate whether SUD patients with and without ADHD (SUD + ADHD vs. SUD − ADHD) differed in QoL at baseline and at a 12-month follow-up after SUD treatment. The groups were additionally compared with data from a national population sample (NPS). From a sample of 16 SUD + ADHD and 87 SUD − ADHD patients originally recruited between 2010 and 2012, eight SUD + ADHD (50.0%) and 28 SUD − ADHD (32.2%) patients were reached at follow-up. QoL was measured with the short version of the World Health Organization QoL instrument (WHOQOL-BREF). Cross-sectional data on QoL from NPS was utilized. Compared to NPS, SUD patients reported significantly lower QoL at baseline and follow-up. Furthermore, QoL was similar at baseline in SUD + ADHD and SUD − ADHD patients. At a 12-month follow-up after SUD treatment, SUD + ADHD patients ‘QoL had improved, however, not significantly differing from SUD − ADHD patients or the NPS. SUD − ADHD patients’ QoL remained significantly lower. At follow-up, SUD + ADHD patients’ QoL improved nominally compared to SUD − ADHD patients, but not the NPS. The clinical and functional relevance of these findings should be investigated further.

Agarwal R, Goldenberg M, Perry R, IsHak WW (2012) The quality of life of adults with attention deficit hyperactivity disorder: a systematic review. Innov Clin Neurosci 9(5–6):10–21PubMedPubMedCentral

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. Author, Washington

American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. Author, WashingtonCrossRef

Arab M, Kohan M, Ranjbar H, Arab N, Rayani M, Mirrashidi SS, Rafiei H, Amiri M (2014) Quality of life, social desirability and their relationship in opium addicted persons in southeast of Iran. Glob J Health Sci 6(3):97–103. https://doi.org/10.5539/gjhs.v6n3p97 CrossRefPubMedPubMedCentral

Babor TF, Higgins-Biddle JC, Saunders JB, Monteiro MG (2001) The Alcohol Use Disorders Identification Test (AUDIT): guidelines for use in primary care, 2nd edn. World Health Organization, Geneva

Berman AH, Bergman H, Palmstierna T, Schlyter F (2005) Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 11(1):22–31CrossRefPubMed

Blome C, Augustin M (2015) Measuring change in quality of life: bias in prospective and retrospective evaluation. Value Health 18(1):110–115. https://doi.org/10.1016/j.jval.2014.10.007 CrossRefPubMed

Brod M, Johnston J, Able S, Swindle R (2006) Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale (AAQoL): a disease-specific quality-of-life measure. Qual Life Res 15(1):117–129. https://doi.org/10.1007/s11136-005-8325-z CrossRefPubMed

Chou YC, Shih SF, Tsai WD, Li CS, Xu K, Lee TS (2013) Improvement of quality of life in methadone treatment patients in northern Taiwan: a follow-up study. BMC Psychiatry 13:190. https://doi.org/10.1186/1471-244x-13-190 CrossRefPubMedPubMedCentral

Clure C, Brady KT, Saladin ME, Johnson D, Waid R, Rittenbury M (1999) Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. Am J Drug Alcohol Abuse 25(3):441–448CrossRefPubMed

Coghill D (2010) The impact of medications on quality of life in attention-deficit hyperactivity disorder: a systematic review. CNS Drugs 24(10):843–866. https://doi.org/10.2165/11537450-000000000-00000 CrossRefPubMed

Crunelle CL, Van Den Brink W, Moggi F, Konstenius M, Franck J, Levin FR, Van De Glind G, Demetrovics Z, Coetzee C, Luderer M, Schellekens A (2018) International consensus statement on screening, diagnosis and treatment of substance use disorder patients with comorbid attention deficit/hyperactivity disorder. Eur Addict Res 24(1):43–51. https://doi.org/10.1159/000487767 CrossRefPubMedPubMedCentral

Daeppen JB, Faouzi M, Sanchez N, Rahhali N, Bineau S, Bertholet N (2014) Quality of life depends on the drinking pattern in alcohol-dependent patients. Alcohol Alcohol 49(4):457–465. https://doi.org/10.1093/alcalc/agu027 CrossRefPubMed

Fatseas M, Debrabant R, Auriacombe M (2012) The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders. Curr Opin Psychiatry 25(3):219–225CrossRefPubMed

First MB, Spitzer RL, Gibbon M, Williams JBW, Benjamin L (1995) Structured clinical interview for DSM-IV (SCID II). State Psychiatric Institute, New York

Flores-Garcia L, Ytterstad E, Lensing MB, Eisemann M (2016) Exploring personality and readiness to change in patients with substance use disorders with and without ADHD. J Atten Disord. https://doi.org/10.1177/1087054716677819 CrossRefPubMed

Gjervan B, Torgersen T, Rasmussen K, Nordahl HM (2014) ADHD symptoms are differentially related to specific aspects of quality of life. J Atten Disord 18(7):598–606CrossRefPubMed

Gjervan B, Torgersen T, Hjemdal O (2016) The Norwegian translation of the adult attention-deficit/hyperactivity disorder quality of life scale: validation and assessment of QoL in 313 adults with ADHD. J Atten Disord 1:1. https://doi.org/10.1177/1087054716640087 CrossRef

Hildebrand M (2015) The psychometric properties of the drug use disorders identification test (DUDIT): a review of recent research. J Subst Abuse Treat 53:52–59CrossRefPubMed

IBM Corp (2013) Released 2013. IBM SPSS statistics for windows (Version 22.0). IBM Corp, Armonk

Kessler RC, Adler L, Ames M, Demler O, Faraone S, Hiripi EV, Howes MJ, Jin R, Secnik K, Spencer T, Ustun TB (2005) The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med 35(2):245–256CrossRefPubMed

Kessler RC, Adler LA, Gruber MJ, Sarawate CA, Spencer T, Van Brunt DL (2007) Validity of the World Health Organization Adult ADHD Self-Report Scale (ASRS) screener in a representative sample of health plan members. Int J Methods Psychiatr Res 16(2):52–65. https://doi.org/10.1002/mpr.208 CrossRefPubMedPubMedCentral

Kim JW, Park CS, Hwang JW, Shin MS, Hong KE, Cho SC, Kim BN (2006) Clinical and genetic characteristics of Korean male alcoholics with and without attention deficit hyperactivity disorder. Alcohol Alcohol 41(4):407–411. https://doi.org/10.1093/alcalc/agl034 CrossRefPubMed

Konstenius M, Jayaram-Lindstrom N, Guterstam J, Beck O, Philips B, Franck J (2014) Methylphenidate for attention deficit hyperactivity disorder and drug relapse in criminal offenders with substance dependence: a 24-week randomized placebo-controlled trial. Addiction 109(3):440–449CrossRefPubMed

Kronenberg LM, Goossens PJ, van Etten DM, van Achterberg T, van den Brink W (2015) Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD). Perspect Psychiatr Care 51(1):4–15. https://doi.org/10.1111/ppc.12056 CrossRefPubMed

Laudet AB (2011) The case for considering quality of life in addiction research and clinical practice. Addict Sci Clin Pract 6(1):44–55PubMedPubMedCentral

Lensing MB, Zeiner P, Sandvik L, Opjordsmoen S (2015) Quality of life in adults aged 50 + with ADHD. J Atten Disord 19(5):405–413. https://doi.org/10.1177/1087054713480035 CrossRefPubMed

Levin FR (2007) Diagnosing attention-deficit/hyperactivity disorder in patients with substance use disorders. J Clin Psychiatry 68(Suppl 11):9–14PubMed

Levin FR, Evans SM, Vosburg SK, Horton T, Brooks D, Ng J (2004) Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addict Behav 29(9):1875–1882. https://doi.org/10.1016/j.addbeh.2004.03.041 CrossRefPubMed

Levin FR, Mariani JJ, Specker S, Mooney M, Mahony A, Brooks DJ, Babb D, Bai Y, Eberly LE, Nunes EV, Grabowski J (2015) Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit/hyperactivity disorder and cocaine use disorder: a randomized clinical trial. JAMA Psychiatry 72(6):593–602. https://doi.org/10.1001/jamapsychiatry.2015.41 CrossRefPubMedPubMedCentral

Luderer M, Kaplan-Wickel N, Richter A, Reinhard I, Kiefer F, Weber T (2018) Screening for adult attention-deficit/hyperactivity disorder in alcohol dependent patients: underreporting of ADHD symptoms in self-report scales. Drug Alcohol Depend 195:52–58. https://doi.org/10.1016/j.drugalcdep.2018.11.020 CrossRefPubMed

Mathiesen EF, Nome S, Eisemann M, Richter J (2012) Drinking patterns, psychological distress and quality of life in a Norwegian general population-based sample. Qual Life Res 21(9):1527–1536. https://doi.org/10.1007/s11136-011-0080-8 CrossRefPubMed

Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L (2009) Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. J Affect Disord 115(1–2):27–35. https://doi.org/10.1016/j.jad.2008.08.019 CrossRefPubMed

Moura HF, Faller S, Benzano D, Szobot C, Von Diemen L, Stolf AR, Souza-Formigoni ML, Cruz MS, Brasiliano S, Pechansky F, Kessler FH (2013) The effects of ADHD in adult substance abusers. J Addict Dis 32(3):252–262. https://doi.org/10.1080/10550887.2013.824359 CrossRefPubMed

Ortal S, van de Glind G, Johan F, Itai B, Nir Y, Iliyan I, van den Brink W (2015) The role of different aspects of impulsivity as independent risk factors for substance use disorders in patients with ADHD: a review. Curr Drug Abuse Rev 8(2):119–133CrossRefPubMed

Owens JS, Goldfine ME, Evangelista NM, Hoza B, Kaiser NM (2007) A critical review of self-perceptions and the positive illusory bias in children with ADHD. Clin Child Fam Psychol Rev 10(4):335–351. https://doi.org/10.1007/s10567-007-0027-3 CrossRefPubMed

Pan PY, Yeh CB (2017) Impact of depressive/anxiety symptoms on the quality of life of adolescents with ADHD: a community-based 1-year prospective follow-up study. Eur Child Adolesc Psychiatry 26(6):659–667. https://doi.org/10.1007/s00787-016-0929-z CrossRefPubMed

Pasareanu AR, Opsal A, Vederhus JK, Kristensen O, Clausen T (2015) Quality of life improved following in-patient substance use disorder treatment. Health Qual Life Outcomes 13:35. https://doi.org/10.1186/s12955-015-0231-7 CrossRefPubMedPubMedCentral

Picci RL, Oliva F, Zuffranieri M, Vizzuso P, Ostacoli L, Sodano AJ, Furlan PM (2014) Quality of life, alcohol detoxification and relapse: is quality of life a predictor of relapse or only a secondary outcome measure? Qual Life Res 23(10):2757–2767. https://doi.org/10.1007/s11136-014-0735-3 CrossRefPubMed

Rumpf HJ, Wohlert T, Freyer-Adam J, Grothues J, Bischof G (2013) Screening questionnaires for problem drinking in adolescents: performance of AUDIT, AUDIT-C, CRAFFT and POSIT. Eur Addict Res 19(3):121–127CrossRefPubMed

Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 88(6):791–804CrossRefPubMed

Sheehan D, Janavs J, Baker R, Harnett-Shehaan K, Knapp E, Sheehan M (1994) Mini international neuropsychiatric interview. University of South Florida, Tampa

Skevington SM, Epton T (2018) How will the sustainable development goals deliver changes in well-being? A systematic review and meta-analysis to investigate whether WHOQOL-BREF scores respond to change. BMJ Glob Health 3(Suppl 1):e000609. https://doi.org/10.1136/bmjgh-2017-000609 CrossRefPubMedPubMedCentral

Sosial-og Helsedirektoratet (2007) Veileder i diagnostikk og behandling av AD/HD: diagnostikk og behandling av hyperkinetisk forstyrrelse/attention deficit hyperactivity disorder (AD/HD) hos barn, ungdom og voksne (IS 1244), revidert utgave ed. Sosial-og Helsedirektoratet, Oslo, Norway [Norwegian Directorate for Health and Social Affairs, 2007. Guide to diagnosis and treatment of AD/HD: Diagnosis and treatment of hyperkinetic disorder/attention deficit hyperactivity disorder (AD/HD) in children, adolescents and adults (IS 1244)]. Author, Oslo

R Core Team (2015) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna. Retrieved from https://www.R-project.org/

Taylor A, Deb S, Unwin G (2011) Scales for the identification of adults with attention deficit hyperactivity disorder (ADHD): a systematic review. Res Dev Disabil 32(3):924–938. https://doi.org/10.1016/j.ridd.2010.12.036 CrossRefPubMed

The WHOQOL Group (1998) Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 28(3):551–558CrossRef

Tracy EM, Laudet AB, Min MO, Kim H, Brown S, Jun MK, Singer L (2012) Prospective patterns and correlates of quality of life among women in substance abuse treatment. Drug Alcohol Depend 124(3):242–249. https://doi.org/10.1016/j.drugalcdep.2012.01.010 CrossRefPubMedPubMedCentral

Uchida M, Spencer TJ, Faraone SV, Biederman J (2015) Adult outcome of ADHD: an overview of results from the MGH longitudinal family studies of pediatrically and psychiatrically referred youth with and without ADHD of both sexes. J Atten Disord. https://doi.org/10.1177/1087054715604360 CrossRefPubMed

Umar MU, Salihu AS, Owolabi SD (2017) Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria. Atten Defic Hyperact Disord 9(3):189–198. https://doi.org/10.1007/s12402-017-0218-9 CrossRefPubMed

van de Glind G, van den Brink W, Koeter MW, Carpentier PJ, van Emmerik-van Oortmerssen K, Kaye S, Skutle A, Bu ET, Franck J, Konstenius M, Moggi F (2013) Validity of the Adult ADHD Self-Report Scale (ASRS) as a screener for adult ADHD in treatment seeking substance use disorder patients. Drug Alcohol Depend 132(3):587–596CrossRefPubMedPubMedCentral

van de Glind G, Konstenius M, Koeter MW, van Emmerik-van Oortmerssen K, Carpentier PJ, Kaye S, Degenhardt L, Skutle A, Franck J, Bu ET, Moggi F (2014) Variability in the prevalence of adult ADHD in treatment seeking substance use disorder patients: results from an international multi-center study exploring DSM-IV and DSM-5 criteria. Drug Alcohol Depend 134:158–166CrossRefPubMed

van Emmerik-van Oortmerssen K, van de Glind G, Koeter MW, Allsop S, Auriacombe M, Barta C, Bu ETH, Burren Y, Carpentier PJ, Carruthers S, Casas M (2014) Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study. Addiction 109(2):262–272. https://doi.org/10.1111/add.12370 CrossRefPubMed

van Emmerik-van Oortmerssen K, Vedel E, Kramer FJ, Blankers M, Dekker JJM, van den Brink W, Schoevers RA (2019) Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: results of a randomized clinical trial. Drug Alcohol Depend 197:28–36. https://doi.org/10.1016/j.drugalcdep.2018.12.023 CrossRefPubMed

Volkow ND, Baler RD (2014) Addiction science: uncovering neurobiological complexity. Neuropharmacology 76(Pt B):235–249CrossRefPubMed

Weiss MD, Gibbins C, Goodman DW, Hodgkins PS, Landgraf JM, Faraone SV (2010) Moderators and mediators of symptoms and quality of life outcomes in an open-label study of adults treated for attention-deficit/hyperactivity disorder. J Clin Psychiatry 71(4):381–390. https://doi.org/10.4088/jcp.08m04709pur CrossRefPubMed

World Health Organization (1992) The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Author, Geneva

Title: Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study
Authors: Lizbett Flores-García
Michael B. Lensing
Elinor Ytterstad
Martin Eisemann
Publication date: 01-09-2019
Publisher: Springer Vienna
Keywords: Attention Deficit Hyperactivity Disorder
Attention Deficit Hyperactivity Disorder
Published in: ADHD Attention Deficit and Hyperactivity Disorders / Issue 3/2019
Print ISSN: 1866-6116
Electronic ISSN: 1866-6647
DOI: https://doi.org/10.1007/s12402-019-00297-5

At a glance: The STEP trials

Springer Medicine

Quality of life in substance use disorder patients with and without attention deficit hyperactivity disorder 12 months after treatment: a naturalistic follow-up study

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2019

Publisher’s Note to: Editors must be vigilant to guarantee the quality and credibility of published scientific work

The positive aspects of attention deficit hyperactivity disorder: a qualitative investigation of successful adults with ADHD

The importance of avoidant personality in social anxiety disorder with and without attention-deficit/hyperactivity disorder

Relational impairments, sluggish cognitive tempo, and severe inattention are associated with elevated self-rated depressive symptoms in adolescents with ADHD

Vitamin D levels in children and adolescents with attention-deficit hyperactivity disorder (ADHD): a meta-analysis

Attention and behavioral control skills in Iranian school children